Inventisbio, Co., Ltd. Class ASSE: 688382

Announcement on Voluntary Announcement of Results of the Phase II Clinical Trial of D-2570

· Issued by Inventisbio, Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Announcement of Results of the Phase II Clinical Trial of D-2570

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis